Funding for this research was provided by:
Received: 29 April 2020
Accepted: 22 October 2020
First Online: 4 November 2020
Ethics approval and consent to participate
: An International Review Board/Independent Ethics Committee approved the RA0098 Clinical Study (NCT03357471) protocol and an Informed Consent form, which was signed by all patients prior to the start of the study. Ethical approval was not required for the two focus groups.
: Patient consent for publication was not required as all data are anonymized.
: VC, KH, BS, IM: Employees of UCB Pharma. FP, AC, SS, SC, JM: Employees of Modus Outcomes.